Delivery Order SPE2DB20D2014-SPE2DB24FA59S
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $103,889.41, is a delivery order for the supply of BIKTARVY 50-200-25 MG TABLET medication. The contract has an ultimate completion date of July 9, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,059.75 firm fixed-price delivery order is for BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of January 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major customer of the company. The $26,205.83 firm fixed price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET, a prescription medication. The contract has a completion date of August 7, 2024. Amerisourcebergen, a leading pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a Delivery Order valued at $7,583.53 awarded by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) with the company. The contract covers the procurement of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product, with an ultimate completion date of October 29, 2024. The contract is a Firm Fixed Price arrangement and does not have a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $39,707.87, is a delivery order for the provision of BIKTARVY 50-200-25 MG TABLET medication. The contract has a firm fixed price and an ultimate completion date of March 18, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $32,271.86 firm fixed-price delivery order contract is for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of January 27, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $12,296.77 awarded by the Defense Logistics Agency (DLA). The award is for the supply of BIKTARVY 50-200-25 MG TABLET, a prescription medication. There is no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $61,576.55, is a Delivery Order for the supply of BIKTARVY 50-200-25 MG TABLET, a prescription medication. The contract has an ultimate completion date of December 31, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $124,435.02 firm fixed-price delivery order is for the medical product "BIKTARVY 50-200-25 MG TABLET UU 30S" and has an ultimate completion date of December 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,706.33 firm fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product. The contract has a period of performance through September 20, 2023 and was awarded on September 19, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FA59SDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,319.74, is a Firm Fixed Price Delivery Order to provide BIKTARVY 50-200-25 MG TABLET UU 30S, a prescription medication. The contract has an ultimate completion date of December 15, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.3k | 12/14/23 |